Related Experiment Video
Updated: Aug 28, 2025

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
Effects of Hypertension on Alzheimer's Disease and Related Disorders
Joseph E Malone1, Mohamed I Elkasaby1, Alan J Lerner2,3
1Department of Neurology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
Insights
High blood pressure (hypertension) contributes to cognitive decline. Treating hypertension with various medications shows promise for improving cognition in dementia patients, though no single drug is superior.
Area of Science:
- Neurology
- Cardiology
- Gerontology
Background:
- Hypertension is a significant risk factor for neurodegenerative dementias, including Alzheimer's disease.
- Cognitive impairment is increasingly linked to elevated blood pressure levels.
- The renin-angiotensin-aldosterone system is implicated in both hypertension and cognitive decline.
Purpose of the Study:
- To review the pathophysiology of hypertension in Alzheimer's disease and related dementias.
- To explore clinical trials investigating hypertension treatment for cognitive improvement.
Main Methods:
- Literature review of pathophysiology and clinical trial data.
- Analysis of studies evaluating antihypertensive agents and their cognitive outcomes.
Main Results:
- Clinical trials suggest blood pressure reduction via antihypertensives can improve cognition.
- Various antihypertensive classes have been studied, with interest in renin-angiotensin-aldosterone system inhibitors.
- No specific antihypertensive agent has demonstrated superiority in reducing dementia risk or providing neuroprotection.
Conclusions:
- Hypertension is a modifiable risk factor for dementia.
- Antihypertensive therapy generally shows favorable outcomes for cognitive function in dementia patients.
- Further research is needed to identify optimal treatment strategies for hypertension in dementia.
Purpose Of Review:
To review the pathophysiology of hypertension in Alzheimer's disease and related dementias and explore the current landscape of clinical trials involving treatment of hypertension to improve cognition.
Recent Findings:
Hypertension is increasingly recognized as a contributor to cognitive impairment. Clinical trials that explore blood pressure reductions with cognitive outcomes have been promising. Various antihypertensives have been evaluated in clinical trials, with growing interest in those agents that impact the renin-angiotensin-aldosterone system due to its own association with cognitive impairment. No antihypertensive agent has been found to be superior to others in reducing cognitive impairment risk or conferring neuroprotective benefits. In this review, the pathophysiology of and clinical trial data involving hypertension and dementia will be explored. Hypertension is a significant risk factor for the development of neurodegenerative dementias, and clinical trials have been overall favorable in improving cognition by reductions in blood pressure using antihypertensive agents.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction

